Molnupiravir 200mg

May 09, 2023

STERIS PHARMA
Molnupiravir 200mg
MOLNUPRIVE is an antiviral medication that has been developed for the treatment of COVID-19. MOLNUPRIVE is an oral medication that is currently undergoing clinical trials to evaluate its safety and efficacy. The recommended dose of MOLNUPRIVE for the treatment of COVID-19 is 800 mg, taken orally, twice daily, for a total of five days. However, the dosage may vary depending on the severity of the illness and other factors, and it is important to follow the instructions provided by a healthcare professional. It is important to note that MOLNUPRIVE is not currently approved for use by the US Food and Drug Administration (FDA) or any other regulatory agency.
For further information please contact: contact@sterispharma.com
Order now: https://www.sterisonline.com/product/molnuprive-200-134019

SHARE WITH